MedTrace Logo

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

NCT01761682 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-07-20

No results posted yet for this study

Summary

The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.

Conditions

  • Leukemia, Acute Lymphoblastic
  • Precursor B-Cell Lymphoblastic Leukemia
  • Leukemia, Biphenotypic, Acute
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • Lymphoblastic Lymphoma

Interventions

OTHER

Diagnosed as ALL

All patients who will be enrolled in this prospective registry are confined to those who are diagnosed as acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, from Jan 2013 till Dec 2047

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Dae-Young Kim, MD, PhD · Associate Professor

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01761682 on ClinicalTrials.gov